3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
69
Carcinoma, Non-Small-Cell Lung
62
Stomach Neoplasms
32
Prostatic Neoplasms
21
Nasopharyngeal Carcinoma
20
Lung Neoplasms
20
Squamous Cell Carcinoma of Head and Neck
11
Esophageal Neoplasms
11
Neoplasm Metastasis
8
Head and Neck Neoplasms
7
Inflammatory Breast Neoplasms
6
Pancreatic Neoplasms
5
Neoplasms
5
HER2-positive Breast Cancer
5
Adenocarcinoma
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
NSCLC
4
Carcinoma, Squamous Cell
4
Sarcoma
3
Nasopharyngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Ovarian Epithelial
3
Breast Diseases
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Tongue Neoplasms
2
Squamous Cell Lung Cancer
2
Interventions
Sorafenib
9
Radiofrequency Ablation
7
Oxaliplatin
7
Fluorouracil
6
Doxorubicin
6
Neoadjuvant Therapy
5
toripalimab
4
lenvatinib
4
Injections
4
Chemotherapy, Adjuvant
4
Bevacizumab
4
sintilimab
3
pembrolizumab
3
Ultrasonography
3
Thalidomide
3
Leucovorin
3
Irinotecan
3
Cisplatin
3
tislelizumab
2
durvalumab
2
camrelizumab
2
anlotinib
2
Walking Speed
2
Standard of Care
2
Radiosurgery
2
Oncolytic Virotherapy
2
Metformin
2
Liver Transplantation
2
Laparoscopy
2
Immunohistochemistry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Liver Neoplasms
×
Docetaxel
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled